Zealand Pharma to Host Q1 2025 Financial Results Call Soon
Zealand Pharma to Present First Quarter 2025 Results
Zealand Pharma A/S, a pioneering biotechnology company known for its innovative peptide-based medicines, is set to host a conference call to discuss its financial performance for the first quarter of 2025. This event is an excellent opportunity for interested parties to gain insights into the company's latest developments.
Details of the Conference Call
The conference call will take place on May 8, 2025, at 2:00 PM CET (8:00 AM ET), immediately following the release of the financial results. Attendees will have the chance to hear from key executives including President and CEO Adam Steensberg, CFO Henriette Wennicke, CMO David Kendall, and CCO Eric Cox. This knowledgeable panel will provide an overview of the company's financial health and operational progress.
Participating Executives
The conference call will include a detailed presentation from the leadership team. After the presentation, there will be a Q&A session allowing attendees to engage directly with the executives and ask pertinent questions about the company's direction and prospects.
Accessing the Call
For those wishing to participate in the call, a live audio webcast will be available, along with accompanying presentation slides. Interested participants should register for the event about ten minutes prior to start time to ensure connectivity. Registration details and unique access codes will be provided upon sign-up.
Recording Availability
If you cannot attend the live session, a recording will be made available on the Investor section of the Zealand Pharma website shortly after the call concludes. This provides an excellent chance for investors and stakeholders to stay updated on the company’s performance while reviewing key insights discussed during the session.
About Zealand Pharma A/S
Founded in 1998, Zealand Pharma A/S is dedicated to the discovery and development of peptide-based therapeutics. The company has successfully moved more than ten of its innovative drug candidates into clinical development, with two already on the market and three more in advanced stages. Zealand Pharma has cultivated numerous partnerships with leading pharmaceutical companies, reinforcing its position in the biotech industry.
Company Vision
Zealand Pharma aims to enhance the quality of life for patients through its cutting-edge medicines, demonstrating a commitment to innovation and excellence. With a solid base in Copenhagen and presence in the U.S., the company continues to expand its impact in biotechnology.
Contact Information
If you would like to learn more or have any inquiries regarding the upcoming call or the company's initiatives, you can reach out to the Zealand Pharma investor relations team:
Adam Lange (Investors)
Vice President, Investor Relations
Email: alange@zealandpharma.com
Neshat Ahmadi (Investors)
Investor Relations Manager
Email: neahmadi@zealandpharma.com
Anna Krassowska, PhD (Investor and Media)
Vice President, Investor Relations & Corporate Communications
Email: akrassowska@zealandpharma.com
Frequently Asked Questions
What is the purpose of the conference call on May 8?
The conference call aims to discuss Zealand Pharma's financial results for the first quarter of 2025 and provide updates on its business activities.
Who will be speaking during the conference call?
The call will feature key executives, including the President, CFO, CMO, and CCO, giving insights into the company's performance and strategy.
How can I access the conference call?
Participants can join via a live audio webcast, with details available upon registration around ten minutes before the event begins.
Will the call be recorded for later access?
Yes, a recording of the conference call will be available on Zealand Pharma's Investor section of their website shortly after the event concludes.
What does Zealand Pharma focus on?
Zealand Pharma is focused on the discovery and development of innovative peptide-based medicines, emphasizing advancements in therapeutic solutions.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
